MCK
McKesson Corporation · Healthcare · Medical Distribution
TECHBuyZACKSHold
R500#216 today
$902.28
+0.38% today · +4.11% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- MCK +0.38% on the last session vs SPY +0.74%: −0.4 pts of stock-specific move.
- Aftermath, big gain (Oct 1): After its 60 big gains in the past 5 years, MCK typically gained 2.4% over the next month (median) and was higher 62% of the time; half the outcomes fell between -1.2% and +5.2%. An ordinary month: +3.0%. Among S&P 500 stocks after big gains, that ranks #86 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 4
In 31 days
EPS estimate
$10.76
$10.53 to $11.26 · 14 analysts
Revenue estimate
$109.9B
$108.8B to $110.8B
Track record
8/8 beats
last 8 reports · moved ±4.9% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 AMC | 1Q2027 | $9.54 | $9.93 | +$0.39 (+4.1%) beat | $105.4B | -0.7% -0.5 vs SPY | +4.0% | +0.2% |
| May 7, 2026 AMC | 4Q2026 | $11.57 | $11.69 | +$0.12 (+1.1%) beat | $96.3B | -2.5% -3.3 vs SPY | -2.0% | -1.0% |
| Feb 4, 2026 AMC | 3Q2026 | $9.27 | $9.34 | +$0.07 (+0.7%) beat | $106.2B | +16.5% +17.8 vs SPY | +4.9% | +16.0% |
| Nov 5, 2025 AMC | 2Q2026 | $9.05 | $9.86 | +$0.81 (+8.9%) beat | $103.2B | +1.7% +2.8 vs SPY | -1.4% | -0.4% |
| Aug 6, 2025 AMC | $8.15 | $8.26 | +$0.11 (+1.3%) beat | — | -5.8% -5.7 vs SPY | -2.9% | -5.8% | |
| May 8, 2025 AMC | $9.83 | $10.12 | +$0.29 (+3.0%) beat | — | +0.5% +0.6 vs SPY | +3.2% | +2.4% | |
| Feb 5, 2025 AMC | $7.99 | $8.03 | +$0.04 (+0.5%) beat | — | -1.2% -1.5 vs SPY | -2.8% | -2.0% | |
| Nov 6, 2024 AMC | $6.87 | $7.07 | +$0.20 (+2.9%) beat | — | +10.6% +9.8 vs SPY | +10.4% | +13.7% | |
| Aug 7, 2024 — | $7.21 | $7.88 | +$0.67 (+9.3%) beat | — | -11.3% -13.7 vs SPY | -7.1% | -10.5% | |
| May 7, 2024 AMC | $6.36 | $6.18 | −$0.18 (−2.8%) miss | — | -0.4% -0.4 vs SPY | +1.2% | +1.1% | |
| Feb 7, 2024 AMC | $7.05 | $7.74 | +$0.69 (+9.8%) beat | — | -4.4% -4.4 vs SPY | -2.3% | -3.0% | |
| Nov 1, 2023 AMC | $6.15 | $6.23 | +$0.08 (+1.3%) beat | — | -2.6% -4.5 vs SPY | -4.0% | +0.2% | |
| Aug 2, 2023 AMC | $5.87 | $7.27 | +$1.40 (+23.9%) beat | — | +5.3% +5.6 vs SPY | +2.3% | +3.7% | |
| May 8, 2023 AMC | $7.12 | $7.19 | +$0.07 (+1.0%) beat | — | +5.5% +5.9 vs SPY | +4.8% | +6.1% | |
| Feb 1, 2023 AMC | $6.36 | $6.90 | +$0.54 (+8.5%) beat | — | -1.2% -2.7 vs SPY | +1.4% | -1.2% | |
| Nov 1, 2022 AMC | $6.10 | $6.06 | −$0.04 (−0.7%) miss | — | +2.0% +4.5 vs SPY | 0.0% | +2.3% | |
| Aug 3, 2022 AMC | $5.30 | $5.83 | +$0.53 (+10.0%) beat | — | +3.3% +3.3 vs SPY | +2.9% | +9.9% | |
| May 5, 2022 AMC | $6.04 | $5.83 | −$0.21 (−3.5%) miss | — | +6.0% +6.5 vs SPY | -0.4% | +2.1% | |
| Feb 2, 2022 AMC | $5.42 | $6.15 | +$0.73 (+13.5%) beat | — | +3.5% +5.8 vs SPY | +4.6% | +7.9% | |
| Nov 1, 2021 AMC | $4.66 | $6.15 | +$1.49 (+32.0%) beat | — | +5.2% +4.8 vs SPY | +3.9% | +5.8% | |
| Aug 3, 2021 AMC | $4.14 | $5.56 | +$1.42 (+34.3%) beat | — | — | — | — | |
| May 6, 2021 AMC | $5.05 | $5.05 | $0.00 (0.0%) in line | — | — | — | — | |
| Feb 2, 2021 BMO | $4.13 | $4.60 | +$0.47 (+11.4%) beat | — | — | — | — | |
| Nov 3, 2020 BMO | $3.88 | $4.80 | +$0.92 (+23.7%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $10.76 (14) | $10.53 – $11.26 | +9% | +0.2% | ▲0 ▼2 | $109.9B | +7% |
| Next quarter · Dec 31, 2026 | $11.02 (14) | $10.41 – $11.66 | +18% | -1.7% | ▲0 ▼2 | $113.1B | +7% |
| Current year · Mar 31, 2027 | $44.65 (16) | $44.32 – $45.25 | +14% | +0.9% | ▲15 ▼0 | $431.8B | +7% |
| Next year · Mar 31, 2028 | $50.41 (16) | $46.77 – $51.74 | +13% | +0.1% | ▲13 ▼3 | $462.2B | +7% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.